Description:LYZZ Capital is a prominent venture capital and private equity firm that specializes in the healthcare sector. With a robust investment portfolio, the firm is currently managing funds in both USD and RMB, amounting to over USD 460 million. The accomplished team at LYZZ Capital consists of seasoned investment and operating professionals who bring extensive experience from leading pharmaceutical and biotech companies, as well as from reputable Wall Street firms. Their backgrounds encompass strong scientific and medical expertise, ensuring a comprehensive approach to investment strategies.
Having collaborated for over a decade, the LYZZ Capital team has developed a culture that values cordiality, flat hierarchies, and a team-oriented working environment. Their collective experience in biotech investments spans more than 15 years, with over a decade of active engagement in the Chinese market. LYZZ Capital focuses its investments on identifying and supporting talent, assets, and innovative technologies on a global scale. The firm places particular emphasis on addressing unmet medical needs and recognizes the significant market potential within China, aligning their investment strategies with the evolving landscape of global healthcare challenges.